Tower Research Capital (TRC)’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.3K Buy
24,183
+3,717
+18% +$11.8K ﹤0.01% 2514
2025
Q4
$75.7K Sell
20,466
-10,267
-33% -$33.2K ﹤0.01% 2142
2025
Q3
$81.4K Buy
30,733
+6,575
+27% +$12.7K ﹤0.01% 2167
2025
Q2
$23.8K Buy
24,158
+19,951
+474% +$20K ﹤0.01% 3582
2025
Q1
$6.06K Sell
4,207
-2,501
-37% -$4.61K ﹤0.01% 4072
2024
Q4
$14.8K Sell
6,708
-3
-0% -$7 ﹤0.01% 3446
2024
Q3
$11.1K Buy
+6,711
New +$13.6K ﹤0.01% 3696
2024
Q2
Sell
-32,173
Closed -$86.2K 5762
2024
Q1
$86.2K Buy
32,173
+22,573
+235% +$54.9K ﹤0.01% 1904
2023
Q4
$28.7K Sell
9,600
-55,914
-85% -$72.5K ﹤0.01% 3451
2023
Q3
$64.2K Buy
65,514
+43,168
+193% +$62.5K ﹤0.01% 2342
2023
Q2
$31.1K Buy
22,346
+1,439
+7% +$2.01K ﹤0.01% 2991
2023
Q1
$33K Buy
20,907
+13,932
+200% +$71.9K ﹤0.01% 2891
2022
Q4
$43K Sell
6,975
-13,290
-66% -$95K ﹤0.01% 2461
2022
Q3
$136K Buy
20,265
+17,319
+588% +$119K ﹤0.01% 2271
2022
Q2
$19K Sell
2,946
-3,993
-58% -$22.6K ﹤0.01% 3838
2022
Q1
$32K Buy
6,939
+5,059
+269% +$21.7K ﹤0.01% 3079
2021
Q4
$9K Sell
1,880
-7,154
-79% -$57.3K ﹤0.01% 4685
2021
Q3
$109K Buy
9,034
+6,293
+230% +$91.6K ﹤0.01% 2329
2021
Q2
$58K Buy
2,741
+1,025
+60% +$24.7K ﹤0.01% 2904
2021
Q1
$49K Buy
1,716
+1,046
+156% +$30.9K ﹤0.01% 3143
2020
Q4
$17K Sell
670
-1,594
-70% -$47.8K ﹤0.01% 3959
2020
Q3
$84K Sell
2,264
-5,546
-71% -$220K ﹤0.01% 3275
2020
Q2
$401K Buy
+7,810
New +$327K 0.02% 1207
2020
Q1
Sell
-1,361
Closed -$81K 3262
2019
Q4
$81K Buy
1,361
+238
+21% +$10.7K 0.01% 1059
2019
Q3
$42K Buy
+1,123
New +$44.5K ﹤0.01% 1916
2019
Q2
Sell
-563
Closed -$23K 3850
2019
Q1
$23K Buy
563
+307
+120% +$13.8K ﹤0.01% 2186
2018
Q4
$12K Buy
+256
New +$12.3K ﹤0.01% 2315
2018
Q3
Sell
-962
Closed -$38K 3893
2018
Q2
$38K Buy
962
+850
+759% +$42.9K ﹤0.01% 2015
2018
Q1
$8K Sell
112
-194
-63% -$14.2K ﹤0.01% 2541
2017
Q4
$20K Buy
+306
New +$16.5K ﹤0.01% 2061
2017
Q3
Sell
-4,863
Closed -$225K 3901
2017
Q2
$225K Buy
4,863
+4,856
+69,371% +$179K 0.03% 314
2017
Q1
$0 Sell
7
-1,518
-100% -$34.8K ﹤0.01% 3265
2016
Q4
$19K Buy
+1,525
New +$18.2K ﹤0.01% 2192
2016
Q3
Sell
-5,240
Closed -$52K 3837
2016
Q2
$52K Buy
5,240
+5,208
+16,275% +$86.3K 0.01% 1519
2016
Q1
$1K Sell
32
-104
-76% -$1.67K ﹤0.01% 3673
2015
Q4
$3K Sell
136
-2,543
-95% -$64.2K ﹤0.01% 3422
2015
Q3
$64K Buy
2,679
+1,830
+216% +$115K 0.01% 843
2015
Q2
$69K Sell
849
-59
-6% -$5.78K 0.01% 1114
2015
Q1
$84K Buy
908
+871
+2,354% +$56.2K 0.01% 1035
2014
Q4
$1K Sell
37
-163
-82% -$4.99K ﹤0.01% 3623
2014
Q3
$5K Buy
+200
New +$3.18K ﹤0.01% 3279
2014
Q2
Sell
-1,745
Closed -$26K 4197
2014
Q1
$26K Sell
1,745
-255
-13% -$3.96K ﹤0.01% 1640
2013
Q4
$27K Buy
2,000
+1,900
+1,900% +$27.6K ﹤0.01% 1986
2013
Q3
$2K Buy
+100
New +$1.68K ﹤0.01% 4096

Other funds holding ESPR